Article History
Received: 28 October 2020
Revised: 28 December 2020
Accepted: 15 January 2021
First Online: 4 February 2021
Compliance with ethical standards
:
: MJS reports membership on the steering committee of trials funded by Akebia with funds paid to Tufts Medical Center; serving as consultant for Cardurian, which is developing potential treatments for heart failure; and having attended an advisory board for Bayer within the past 2 years.
: The authors declare that they have no conflict of interest.